title: Cytoskeletal dissociation of ezrin during renal anoxia: role in microvillar injury.
abstract: The association/dissociation of ezrin, a microvillar membrane-cytoskeleton linker, was studied to search for the initial step leading to anoxia-induced brush-border breakdown in a rabbit proximal tubule suspension. Electron microscopy studies display time-dependent damage to the microvilli during anoxia; immunoblots demonstrate the dissociation of ezrin from the cytoskeleton, reflected by the significant decrease in Triton X-100-insoluble ezrin from control (91%) to 39% after 30 min. Simultaneously, Triton X-100-soluble and extracellular ezrin increased with no change in total ezrin, Triton X-100 solubility of actin, or total intracellular protein. Parallel immunocytochemistry studies show diffusion of ezrin from the brush border, where ezrin is highly colocalized with F-actin during normoxia into the cytoplasm. Thirty minutes of reoxygenation following 30 min of anoxia causes recovery of the microvillar structure and reassociation of ezrin to the cytoskeleton and the brush border. Application of ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (4 mM) or inhibition of intracellular calpain or calcineurin do not prevent the dissociation of ezrin during anoxia. We conclude that ezrin-cytoskeletal dissociation may initiate microvillar breakdown during anoxia via calcium-independent mechanisms.
authors.affiliation: Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710.
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.forename: R B
authors.initials: RB
authors.lastname: Doctor
authors.forename: L J
authors.initials: LJ
authors.lastname: Mandel
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D003598:Cytoskeletal Proteins; D003599:Cytoskeleton / Q000378:metabolism*; D003600:Cytosol / Q000378:metabolism; D005260:Female; D005455:Fluorescent Antibody Technique; D005998:Glycine / Q000494:pharmacology; D000860:Hypoxia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007674:Kidney Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D008871:Microvilli / Q000502:physiology / Q000648:ultrastructure; D017830:Octoxynol; D010100:Oxygen / Q000494:pharmacology; D010750:Phosphoproteins / Q000378:metabolism*; D011817:Rabbits; D012995:Solubility; D014018:Tissue Distribution; D000099149:Ezrin
chemical_list: D000199:Actins; D000968:Antimycin A; D003598:Cytoskeletal Proteins; D005998:Glycine; D017830:Octoxynol; D010100:Oxygen; D010750:Phosphoproteins; D000099149:Ezrin